Global Atherectomy Device Market is estimated to grow at a CAGR exceeding 6% from 2015 to 2022. Increasing prevalence of peripheral artery disease (PAD) and deep vein thrombosis (DVT) is expected to drive the market over the forecast period.
Rising chronic illness in mature economies including the U.S. and UK is expected to raise medical devices demand in near future. Factors such as rising life expectancy and declining fertility rates are expected to positively impact market growth over the foreseeable future.
Full research report on Atherectomy Device Market Analysis: http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market
Changing lifestyle and eating habits is anticipated to raise cholesterol level on account of increased fatty foods consumption among individuals. These factors coupled with lack of exercise have been a major reason for coronary artery disease in the past. Prevalence of diabetes, high blood pressure, obesity and smoking cause the blood arteries to become narrow and limit blood supply to the heart.
It is estimated that over 382 billion people have diabetes globally. Environmental factors such as foods, viruses, toxins and unbalanced work life play a major role in development of diabetes. Growing number of patients with these vascular diseases are expected to raise atherectomy devices demand over the forecast period.
Atherectomy devices help in plaque removal, particularly calcified plaque, by physically drilling, pulverizing or shaving it. This technique is a popular substitute for stents and angioplasty treatments. In stents and angioplasty the deposited plaque is pushed inside the blood vessel. However, in atherectomy the plaque is removed by using surgical methods. This technique has advantages over other methods by providing increased wound healing rate. The aforementioned factor is expected to drive the market over the next seven years.
Get more information on Atherectomy Device Market or request for TOC of this research report at: http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market/request-toc
Advanced technology adoption by using laser, ultraviolet radiation, recombinant issue technology and 3D image generation is anticipated to provide a better scope for the market. Added benefits such as minimal incisions, higher surgical restoration rate, and low postoperative complications are anticipated to increase patients opting for atherectomy devices. FDA approval of two drug coated balloons is expected to increase product demand over the forecast period.
Recalls of medical devices has been a major issue in pharmaceutical industry. Every device should maintain the standard quality and safety measures set by the Food and Drug Administration (FDA). Manufacturing firms must ensure strict adherence to device quality.
Athrectomy devices face a tough competition from catheter (Tornus) which has been developed for chronic total occlusion recanalization. However catheter has a lower success rate of 77% as compared to the traditional atherectomy devices with 95%. Tornus catheter is also associated with longer procedural duration time with 144 minutes versus the atherectomy devices 115 minutes.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States